Commissioner of health directed to study and report on activities to support innovations in cell and gene therapy to treat rare diseases, report required, and money appropriated.

Summary

The bill orders Minnesota’s commissioner of health, together with the University of Minnesota and the Rare Disease Advisory Council, to conduct a comprehensive study of the state’s ability to develop, deliver, and access cell and gene therapies for rare diseases. The study must gather input from patients, caregivers, providers, industry and other stakeholders, and a report with findings and recommendations is due by Jan. 1, 2028. Money is appropriated to fund the study.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share